IM Cannabis (IMCC) Cost of Revenue (2020 - 2026)

IM Cannabis' Cost of Revenue history runs 7 years deep, the most recent figure standing at $5.3 million for Q1 2026.

• In Q1 2026, Cost of Revenue fell 16.08% year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $31.3 million (down 2.25% YoY), while the FY2025 annual figure was $32.3 million, down 2.98% from the prior year.
• Cost of Revenue was $5.3 million for Q1 2026 at IM Cannabis, down from $11.2 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $11.2 million in Q4 2025 to a low of $5.3 million in Q1 2026.
• Historically, Cost of Revenue has averaged $7.8 million across 5 years, with a median of $7.6 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue soared 139.3% in 2022, then sank 34.19% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $8.6 million in 2022, then retreated by 18.13% to $7.0 million in 2023, then increased by 8.36% to $7.6 million in 2024, then jumped by 46.68% to $11.2 million in 2025, then tumbled by 52.68% to $5.3 million in 2026.
• The last three Cost of Revenue figures came in at $5.3 million (Q1 2026), $11.2 million (Q4 2025), and $8.1 million (Q3 2025), per Business Quant data.